BeMORE: A Novel Method for Detection of Adverse Fetal Effects Induced by Drugs

Title: BeMORE: A Novel Method for Detection of Adverse Fetal Effects Induced by Drugs

Volume: 6 Issue: 1

Author(s): Ilan Matok, Amalia Levy, Rafael Gorodischer, Eitan Lunenfeld, Yehuda Limony and Gideon Koren

Affiliation:

Keywords: Pregnancy, malformations, medication, fetus, neonate, BeMORE, Drugs, central nervous system, corticosteroids, Clalit Health Services, Demog-ICD9 database, CDC, ORs, CIs, congenital malformations, neural tube, cardiovascular defects, abortion

Abstract: We describe a unique new collaboration which allows linkage of administrative databases in Southern Israel, and hence ascertain risk/safety of prescription drugs in pregnancy. The advantages of this system include availibilty of rigorous data confounders, solid data on maternal conditions for which the drug is given, ability to capture all cases of elective abortions and not just live births, and ability to construct drug doses.

Cite this article as:

Matok Ilan, Levy Amalia, Gorodischer Rafael, Lunenfeld Eitan, Limony Yehuda and Koren Gideon, BeMORE: A Novel Method for Detection of Adverse Fetal Effects Induced by Drugs, Current Drug Safety 2011; 6 (1) . https://dx.doi.org/10.2174/157488611794480052